This review aims to comprehensively explore the role of S100A8/A9 in ASCVD and ischemic heart disease, HF, and cardiac arrhythmogenesis, and to discuss its pathophysiological implications, clinical significance, and potential utility as a therapeutic target to improve cardiovascular outcomes. Here, IGKV1D-22 is linked to atherosclerosis.